These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 12902892)

  • 1. Genetic alterations and MSI status in primary, synchronous, and metachronous tumors in a family with hereditary nonpolyposis colorectal cancer (HNPCC).
    González-Aguilera JJ; Nejda N; Fernández FJ; Medina V; González-Hermoso F; Barrios Y; Moreno Azcoita M; Fernández-Peralta AM
    Am J Clin Oncol; 2003 Aug; 26(4):386-91. PubMed ID: 12902892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium.
    Shannon C; Kirk J; Barnetson R; Evans J; Schnitzler M; Quinn M; Hacker N; Crandon A; Harnett P
    Clin Cancer Res; 2003 Apr; 9(4):1387-92. PubMed ID: 12684409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of microsatellite instability and loss of mismatch-repair protein expression in patients with double primary tumors of the endometrium and colorectum.
    Planck M; Rambech E; Möslein G; Müller W; Olsson H; Nilbert M
    Cancer; 2002 May; 94(9):2502-10. PubMed ID: 12015776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of endometrial cancer meeting new clinical criteria for hereditary nonpolyposis colorectal cancer.
    Sagawa T; Yamada H; Yamamoto R; Sakuragi N; Fujimoto S
    Gynecol Oncol; 2000 Nov; 79(2):327-31. PubMed ID: 11063667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
    J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
    Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
    J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
    Rouprêt M; Yates DR; Comperat E; Cussenot O
    Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
    Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
    Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
    Boland CR; Thibodeau SN; Hamilton SR; Sidransky D; Eshleman JR; Burt RW; Meltzer SJ; Rodriguez-Bigas MA; Fodde R; Ranzani GN; Srivastava S
    Cancer Res; 1998 Nov; 58(22):5248-57. PubMed ID: 9823339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
    Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
    Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MSI-low, a real phenomenon which varies in frequency among cancer types.
    Halford SE; Sawyer EJ; Lambros MB; Gorman P; Macdonald ND; Talbot IC; Foulkes WD; Gillett CE; Barnes DM; Akslen LA; Lee K; Jacobs IJ; Hanby AM; Ganesan TS; Salvesen HB; Bodmer WF; Tomlinson IP; Roylance RR
    J Pathol; 2003 Nov; 201(3):389-94. PubMed ID: 14595750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.
    Woerner SM; Kloor M; Schwitalle Y; Youmans H; Doeberitz Mv; Gebert J; Dihlmann S
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1080-9. PubMed ID: 17726700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer.
    Müller A; Edmonston TB; Corao DA; Rose DG; Palazzo JP; Becker H; Fry RD; Rueschoff J; Fishel R
    Cancer Res; 2002 Feb; 62(4):1014-9. PubMed ID: 11861375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
    Lipton LR; Johnson V; Cummings C; Fisher S; Risby P; Eftekhar Sadat AT; Cranston T; Izatt L; Sasieni P; Hodgson SV; Thomas HJ; Tomlinson IP
    J Clin Oncol; 2004 Dec; 22(24):4934-43. PubMed ID: 15611508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer.
    Watson P; Bützow R; Lynch HT; Mecklin JP; Järvinen HJ; Vasen HF; Madlensky L; Fidalgo P; Bernstein I;
    Gynecol Oncol; 2001 Aug; 82(2):223-8. PubMed ID: 11531271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of rapid microsatellite analysis of paraffin-embedded specimens in screening for hereditary nonpolyposis colorectal cancer.
    Raedle J; Brieger A; Trojan J; Hardt T; Herrmann G; Zeuzem S
    Mod Pathol; 1999 May; 12(5):485-91. PubMed ID: 10349986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation.
    Buttin BM; Powell MA; Mutch DG; Rader JS; Herzog TJ; Gibb RK; Huettner P; Edmonston TB; Goodfellow PJ
    Clin Cancer Res; 2004 Jan; 10(2):481-90. PubMed ID: 14760069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instabilities in gastric cancer patients with multiple primary cancers.
    Yokozaki H; Semba S; Fujimoto JY; Tahara E
    Int J Oncol; 1999 Jan; 14(1):151-5. PubMed ID: 9863022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.